Shifting phase
Oral and vaginal mucosa share the same essential physics: richly vascularized tissue that can accept a polymer yielding at body temperature. That shared physiology is why Phasys is one foundational science — engineered into three Instasolv formats, not three unrelated products.
Select a step to inspect the transition — from placement, through the thermal phase shift, into mucosal uptake.
Each Instasolv presentation is a specification of Phasys — tuned to a tissue, a handling requirement, and a clinical route.
A fast-dissolving film that yields on contact with the richly vascularized tissue of the mouth — built for patients who cannot, or will not, swallow.
The same phase-transition chemistry in a dense, dose-precise matrix — familiar handling for formulators, without surrendering speed at the tissue interface.
Phasys thermoresponsive chemistry engineered for vaginal mucosa — opening both localized and systemic delivery on a single polymer platform.
Instasolv is developed in partnership with cGMP-compliant, FDA-registered U.S. facilities — moving every formulation from lab to scale under audit-ready quality systems, not a garage-stage promise.
We’re looking for pharmaceutical partners, biotech innovators, and investigators ready to put Instasolv to work on their next molecule.